Market Place
Sourcing Support
FDA approvals rise 49% in 2023; CRISPR’s gene editing therapy sees light of day
In 2022, when the
US Food and Drug Administration (FDA) was reeling under the impact of the
pandem
India leads DMF submissions to the FDA during Q4 of 2016 and Q1 of 2017
A review of the Drug Master Files (DMFs) submitted to the United
States Food and Drug Administration
